Serum Phosphate as a Risk Factor for Cardiovascular Events in People with and without Chronic Kidney Disease: A Large Community Based Cohort Study

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  McGovern, Andrew Peter ^a   de Lusignan, Simon ^a,b   van Vlymen, Jeremy ^a   Liyanage, Harshana ^a   Tomson, Charles Richard ^c   Gallagher, Hugh ^b,d   Rafiq, Meena ^a   Jones, Simon ^a  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^c NORTH BRISTOL NHS TRUST   (United Kingdom)

^d ST HELIER HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATE;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HUMAN; HYPOPHOSPHATEMIA; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR;

ADULT; AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; ENGLAND; FEMALE; FOLLOW-UP STUDIES; HOMEOSTASIS; HUMANS; LOGISTIC MODELS; MALE; MEDICAL RECORDS SYSTEMS, COMPUTERIZED; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PHOSPHATES; PROPORTIONAL HAZARDS MODELS; PROTEINURIA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TREATMENT OUTCOME;

EID: 84883746986     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0074996     Document Type: Article

References (45)

1. Kestenbaum B, Sampson JN, Rudser KD, Patterson DJ, Seliger SL, et al. (2005) Serum phosphate levels and mortality risk among people with chronic kidney disease. Journal of the American Society of Nephrology: JASN 16: 520-528.
2. Block GA, Hulbert-Shearon TE, Levin NW, Port FK, (1998) Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. American journal of kidney diseases: the official journal of the National Kidney Foundation 31: 607-617.
3. Palmer SC, Hayen A, Macaskill P, Pellegrini F, Craig JC, et al. (2011) Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis. JAMA: the journal of the American Medical Association 305: 1119-1127.
4. Gonzalez-Parra E, Tunon J, Egido J, Ortiz A, (2012) Phosphate: a stealthier killer than previously thought? Cardiovasc Pathol 21: 372-381.
5. Jung HH, Kim SW, Han H, (2006) Inflammation, mineral metabolism and progressive coronary artery calcification in patients on haemodialysis. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association 21: 1915-1920.
6. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG, (2008) Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association 23: 586-593.
7. Cunningham J, Locatelli F, Rodriguez M, (2011) Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options. Clin J Am Soc Nephrol 6: 913-921.
8. Foley RN, Collins AJ, Herzog CA, Ishani A, Kalra PA, (2009) Serum phosphorus levels associate with coronary atherosclerosis in young adults. J Am Soc Nephrol 20: 397-404.
9. Linefsky JP, O'Brien KD, Katz R, de Boer IH, Barasch E, et al. (2011) Association of Serum Phosphate Levels with Aortic Valve Sclerosis and Annular Calcification: the Cardiovascular Health Study. J Am Coll Cardiol 58: 291-297.
10. Tonelli M, Sacks F, Pfeffer M, Gao Z, Curhan G, (2005) Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 112: 2627-2633.
11. Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, et al. (2007) Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Archives of internal medicine 167: 879-885.
12. Foley RN, Collins AJ, Ishani A, Kalra PA, (2008) Calcium-phosphate levels and cardiovascular disease in community-dwelling adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 156: 556-563.
13. Abramowitz M, Muntner P, Coco M, Southern W, Lotwin I, et al. (2010) Serum alkaline phosphatase and phosphate and risk of mortality and hospitalization. Clin J Am Soc Nephrol 5: 1064-1071.
14. Mathew S, Tustison KS, Sugatani T, Chaudhary LR, Rifas L, et al. (2008) The mechanism of phosphorus as a cardiovascular risk factor in CKD. Journal of the American Society of Nephrology: JASN 19: 1092-1105.
15. Lau WL, Pai A, Moe SM, Giachelli CM, (2011) Direct Effects of Phosphate on Vascular Cell Function. Adv Chronic Kidney Dis 18: 105-112.
16. Jono S, McKee MD, Murry CE, Shioi A, Nishizawa Y, et al. (2000) Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 87: E10-17.
17. Raggi P, Boulay A, Chasan-Taber S, Amin N, Dillon M, et al. (2002) Cardiac calcification in adult hemodialysis patients. A link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol 39: 695-701.
18. Yildiz A, Memisoglu E, Oflaz H, Yazici H, Pusuroglu H, et al. (2005) Atherosclerosis and vascular calcification are independent predictors of left ventricular hypertrophy in chronic haemodialysis patients. Nephrol Dial Transplant 20: 760-767.
19. Amann K, Tornig J, Kugel B, Gross ML, Tyralla K, et al. (2003) Hyperphosphatemia aggravates cardiac fibrosis and microvascular disease in experimental uremia. Kidney international 63: 1296-1301.
20. Chue CD, Townend JN, Steeds RP, Ferro CJ, (2010) Arterial stiffness in chronic kidney disease: causes and consequences. Heart 96: 817-823.
21. Van TV, Watari E, Taketani Y, Kitamura T, Shiota A, et al. (2012) Dietary phosphate restriction ameliorates endothelial dysfunction in adenine-induced kidney disease rats. J Clin Biochem Nutr 51: 27-32.
22. Terai K, Nara H, Takakura K, Mizukami K, Sanagi M, et al. (2009) Vascular calcification and secondary hyperparathyroidism of severe chronic kidney disease and its relation to serum phosphate and calcium levels. British journal of pharmacology 156: 1267-1278.
23. Gutierrez OM, Isakova T, Enfield G, Wolf M, (2011) Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey. J Ren Nutr 21: 140-148.
24. Ritz E, Hahn K, Ketteler M, Kuhlmann MK, Mann J, (2012) Phosphate Additives in Food-a Health Risk. Dtsch Arztebl Int 109: 49-55.
25. de Lusignan S, Gallagher H, Jones S, Chan T, van Vlymen J, et al. (2013) Audit-based education lowers systolic blood pressure in chronic kidney disease: the Quality Improvement in CKD (QICKD) trial results. Kidney Int.
26. de Lusignan S, Gallagher H, Chan T, Thomas N, van Vlymen J, et al. (2009) The QICKD study protocol: a cluster randomised trial to compare quality improvement interventions to lower systolic BP in chronic kidney disease (CKD) in primary care. Implementation science: IS 4: 39.
27. Abutaleb N, (2007) Why we should sub-divide CKD stage 3 into early (3a) and late (3b) components. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association 22: 2728-2729.
28. National Institute for Health and Clinical Excellence (2008) Chronic Kidney Disease. Early Identification and management of chronic kidney disease in adults in primary and secondary care. Available: http://www.nice.org.uk/cg73. Accessed 14 August 2013.
29. de Lusignan S, Khunti K, Belsey J, Hattersley A, van Vlymen J, et al. (2010) A method of identifying and correcting miscoding, misclassification and misdiagnosis in diabetes: a pilot and validation study of routinely collected data. Diabet Med 27: 203-209.
30. Maindonald J, Braun J (2010) Data Analysis and Graphics Using R: An Example-based Approach (Cambridge Series in Statistical and Probabilistic Mathematics). Cambridge: Cambridge University Press.
31. Bates D, Maechler M, Bolker B (2012) lme4: Linear mixed-effects models using S4 classes Available: http://CRAN.R-project.org/package=lme4.Accessed 14 August 2013.
32. de Lusignan S, Sadek N, Mulnier H, Tahir A, Russell-Jones D, et al. (2012) Miscoding, misclassification and misdiagnosis of diabetes in primary care. Diabet Med 29: 181-189.
33. Roderick P, Roth M, Mindell J (2011) Prevalence of chronic kidney disease in England: Findings from the 2009 Health Survey for England. Journal of epidemiology and community health 65.
34. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS, (2009) Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation 119: 3078-3084.
35. O'Seaghdha CM, Hwang SJ, Muntner P, Melamed ML, Fox CS, (2011) Serum phosphorus predicts incident chronic kidney disease and end-stage renal disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association- European Renal Association 26: 2885-2890.
36. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, et al. (2004) Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 15: 2208-2218.
37. Felsenfeld AJ, Levine BS, (2012) Approach to treatment of hypophosphatemia. Am J Kidney Dis 60: 655-661.
38. Stenvinkel P, Heimburger O, Paultre F, Diczfalusy U, Wang T, et al. (1999) Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55: 1899-1911.
39. Kemp GJ, Blumsohn A, Morris BW, (1992) Circadian changes in plasma phosphate concentration, urinary phosphate excretion, and cellular phosphate shifts. Clin Chem 38: 400-402.
40. Pocock SJ, Ashby D, Shaper AG, Walker M, Broughton PM, (1989) Diurnal variations in serum biochemical and haematological measurements. J Clin Pathol 42: 172-179.
41. Lynch KE, Lynch R, Curhan GC, Brunelli SM, (2011) Prescribed dietary phosphate restriction and survival among hemodialysis patients. Clin J Am Soc Nephrol 6: 620-629.
42. Guida B, Piccoli A, Trio R, Laccetti R, Nastasi A, et al. (2011) Dietary phosphate restriction in dialysis patients: a new approach for the treatment of hyperphosphataemia. Nutr Metab Cardiovasc Dis 21: 879-884.
43. Navaneethan SD, Palmer SC, Craig JC, Elder GJ, Strippoli GF, (2009) Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials. American journal of kidney diseases: the official journal of the National Kidney Foundation 54: 619-637.
44. Di Iorio B, Bellasi A, Russo D, (2012) Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol 7: 487-493.
45. Lamb EJ, MacKenzie F, Stevens PE, (2009) How should proteinuria be detected and measured? Annals of clinical biochemistry 46: 205-217.